Company

Nanocarry Therapeutics

Biotechnology Research Science Park, Il 11 employees

Employees: 11
Contacts: 3
Emails: 3
Phones: 1

www.nanocarry.com LinkedIn Crunchbase

Nanocarry Therapeutics Overview

Headquarters: Science Park, Il
Website: www.nanocarry.com
Industry: Biotechnology Research
Employees: 11
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

blood brain barrier immuno-oncology nanoparticles antibodies biologics neurodegenerative disease nanotechnology drug delivery

About Nanocarry Therapeutics

Nanocarry is developing a new class of therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. Using a proprietary “Plug and Play” approach, Nanocarry’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.

Nanocarry Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Nanocarry Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Michal Roytman Haham	Chief Business Officer at Nanocarry	Israel	Email
Omri Amirav-Drory	General Partner at Nfx	Menlo Park, California, United States	Email Phone
Oshra Betzer	Founder & COO at Nanocarry Therapeutics	Israel	Email
Rachela Popovtzer	Full Professor at Bar-ilan University		View